NAS:WGS Key Ratios
| Market Cap $ M | 2,676.27 |
| Enterprise Value $ M | 2,711.13 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | 64.01 |
| Price/Book | 10.94 |
| Price/Sales | 5.78 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 454.00 |
| EPS (TTM) $ | -3.64 |
| Beneish M-Score | -2.26 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -325.30 |
| EV-to-EBIT | -28.16 |
| EV-to-EBITDA | -39.07 |
| PEG | -- |
| Shares Outstanding M | 29.82 |
| Net Margin (%) | -23.41 |
| Operating Margin % | -12.96 |
| Pre-tax Margin (%) | -23.39 |
| Quick Ratio | 3.06 |
| Current Ratio | 3.30 |
| ROA % (ttm) | -21.54 |
| ROE % (ttm) | -38.65 |
| ROIC % (ttm) | -19.11 |
| Dividend Yield % | -- |
| Altman Z-Score | 2.86 |
WGS Number of Guru Trades
WGS Volume of Guru Trades
Gurus Latest Trades with NAS:WGS
NAS:WGS is held by these investors
GeneDx Holdings Corp Insider Transactions
Guru Commentaries on NAS:WGS
GeneDx is a provider of genomic testing and diagnostics, using advanced sequencing technology to help clinicians diagnose rare diseases and inform treatment decisions. Despite the company continuing to report solid revenue growth and improving profitability, there has been some variability in testing volumes and reimbursement dynamics, which created modest uncertainty. Additionally, broader volatility across high-growth healthcare names has weighed on sentiment, leading to a decision to scale back exposure to GeneDx in the portfolio.
GeneDx is a specialty laboratory focused on genetic testing for the diagnosis of rare diseases, primarily targeting pediatric patients in neonatal intensive care units and those with developmental disorders. The company reported strong fiscal fourth-quarter results, driven by robust customer demand. Additionally, management raised their fiscal 2025 revenue guidance, exceeding analyst estimates, which indicates a positive outlook for the company's growth trajectory.
News about NAS:WGS
Total 0- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
